Skip to main navigation
Skip to search
Skip to main content
Ariel University Home
Help & FAQ
Link opens in a new tab
English
עברית
العربية
Search content at Ariel University
Home
Profiles
Research units
Equipment
Research output
Prizes
Activities
Press/Media
Treatment of epilepsy in pregnancy
Irena Nulman
, Dionne Laslo
, Gideon Koren
Research output
:
Contribution to journal
›
Review article
›
peer-review
70
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment of epilepsy in pregnancy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Anticonvulsant
100%
Epilepsy Treatment
100%
Epilepsy in Pregnancy
100%
Epilepsy
42%
Seizure Control
42%
Phytomenadione
42%
During Pregnancy
28%
Teratogenicity
28%
Folic Acid
28%
Phenytoin
28%
Women with Epilepsy
28%
Antenatal Management
28%
Postpartum Management
28%
Human Teratogens
14%
First Trimester
14%
Patient Education
14%
Adverse Pregnancy Outcomes
14%
Convulsion
14%
Birth Defects
14%
Neonate
14%
Breast
14%
Third Trimester
14%
Benzodiazepines
14%
Bleeding
14%
Neural Tube Defects
14%
Alpha-fetoprotein
14%
Maternal Serum
14%
Malformation
14%
Favorable Outcome
14%
Metabolism
14%
Expected Date of Delivery
14%
Ultrasound Examination
14%
Carbamazepine
14%
Patient Assessment
14%
Risk Perception
14%
Therapeutic Drug Monitoring
14%
Contraception
14%
Phenobarbital
14%
Genetic Predisposition
14%
Preconceptional
14%
Seizure Activity
14%
Hormonal Changes
14%
Preconception Counseling
14%
Vitamin K
14%
Psychological Changes
14%
Convulsive Disorders
14%
Folic Acid Deficiency
14%
Genetic Counseling
14%
Dysmorphology
14%
Immediately after Birth
14%
Seizure Cessation
14%
Clinically Indicated
14%
Uncontrolled Seizures
14%
Pregnant Women with Epilepsy
14%
Both Parents
14%
Epilepsy Type
14%
Lowest Effective Dose
14%
Pharmacokinetic Change
14%
Early Neonatal
14%
New Anticonvulsant
14%
Pharmacology, Toxicology and Pharmaceutical Science
Anticonvulsive Agent
100%
Epilepsy
100%
Phytomenadione
37%
Congenital Malformation
25%
Teratogenicity
25%
Folic Acid
25%
Phenytoin
25%
Teratogenic Agent
12%
Fetoprotein
12%
Neural Tube Defect
12%
Folic Acid Deficiency
12%
Carbamazepine
12%
Therapeutic Drug Monitoring
12%
Phenobarbital
12%
Genetic Predisposition
12%
Neonatal Hemorrhage
12%
Vitamin K Group
12%
Pharmacokinetics
12%
Diseases
12%
Convulsion
12%